Business
Distribution agreement
Distribution agreement.
About this update from Probiotix Health Plc
[{"type":"text","content":"\n\nProBiotix Health plc\n(\"ProBiotix\" or the \"Company\")\n \nDistribution agreement\nDistribution of finished turnkey products in Australia and New Zealand\n \nProBiotix Health plc (AQSE: PBX), a life sciences business developing probiotics to tackle lifestyle conditions such as cardiovascular disease, announces that the Company has signed an exclusive distribution agreement with Trans Chem to cover the Australian and New Zealand probiotics market.\n \nTrans Chem is one of Australia's leading independent suppliers of innovative products and quality raw ingredients for the pharmaceutical, nutraceutical, food and beverage,veterinary and animal nutrition industries. Trans Chem's operations extend across both Australia and New Zealand. Trans Chem's customers include all the major leading pharma and nutraceutical brand owners in the region and the numerous contract manufacturers who service and support these players. They also have a strong emerging international food and beverage business. The Directors believe that Trans Chem is a strong and creditable company, winning 'Prestigious Quality Material Supplier of the Year' awarded by the Complementary Medicines Australia (CMA) in 2016, 2019 and in 2021.\n \nSteen Andersen, CEO of ProBiotix Health plc commented: \"We are delighted to have signed this agreement with Trans Chem, which will further enhance our global reach. Although our primary strategic focus is on developing the European and North American markets, we believe that there is a significant business potential in Australia & New Zealand. Both countries have a high concentration of dietary supplement companies acting as a gateway into servicing mainland China and the Southeast Asian region, which we can now capitalise on.\n \n\"Trans Chem is a leading distributor in the region and will be responsible for selling our finished turn-key product solutions based on LPLDL® into the leading brands in the regions. The finished turn-key product solutions will be manufactured through local Australian and New Zealand contract manufacturing organisations (CMO's), controlled by ProBiotix Health in cooperation with Trans Chem.\" \n \nFor further information, please contact:\n \n\n\n\n\nProBiotix Health plc\n\n\nhttps://probiotixhealth-ir.com/\n\n\n\n\nSteen Andersen, Chief E...